找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Adult and Pediatric Neuromodulation; Jason P. Gilleran,Seth A. Alpert Book 2018 Springer International Publishing AG, part of Springer Nat

[復(fù)制鏈接]
樓主: 警察在苦笑
31#
發(fā)表于 2025-3-26 23:58:04 | 只看該作者
32#
發(fā)表于 2025-3-27 02:11:42 | 只看該作者
https://doi.org/10.1007/978-1-4302-2794-6nt option that has been studied extensively in patients with severe and refractory OAB. SNM significantly reduces urgency, frequency, and incontinence while also improving quality of life. Although SNM is not currently indicated for the treatment of OAB symptoms due to neurologic disease, recent lit
33#
發(fā)表于 2025-3-27 06:53:50 | 只看該作者
Interfacing to the Operating System, emptying can be found. This poses unique challenges to treating clinicians, and until recently, management was limited to physical therapy, assisted emptying with intermittent catheterization, foley catheter placement, or urinary diversion. Neuromodulation, in multiple forms, offers a minimally inv
34#
發(fā)表于 2025-3-27 10:11:31 | 只看該作者
Interfacing to the Operating System,tion system. PNE has been used since 1997 for the initial test phase and maintains many advantages. Advances in lead wire technology have increased the frequency of the initial test phase being performed in the operating room; however, this is an expensive and labor intensive technique. PNE is an of
35#
發(fā)表于 2025-3-27 14:14:42 | 只看該作者
36#
發(fā)表于 2025-3-27 20:27:14 | 只看該作者
https://doi.org/10.1007/978-1-4302-2794-6ctive bladder, non-obstructive urinary retention, and fecal incontinence. Since its introduction in the early 2000s, it continues to experience a “coming of age”. As a result, pudendal neuromodulation is perhaps settling into the unique role as an alternative approach to those who have failed sacral
37#
發(fā)表于 2025-3-27 22:57:07 | 只看該作者
38#
發(fā)表于 2025-3-28 05:21:57 | 只看該作者
39#
發(fā)表于 2025-3-28 09:25:25 | 只看該作者
Interfacing to the Operating System,tibial nerve at the ankle. PTNS is a minimally invasive technique that requires no permanent lead or implanted stimulator. It is currently approved by the United States Food and Drug Administration (FDA) for the treatment of overactive bladder (OAB) and its associated frequency, urgency, and urgency
40#
發(fā)表于 2025-3-28 14:01:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 12:37
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
诸暨市| 利川市| 军事| 漳平市| 博野县| 保康县| 盐池县| 襄汾县| 牟定县| 那曲县| 南召县| 南投市| 临沭县| 松桃| 兰西县| 乃东县| 靖江市| 和硕县| 南平市| 中宁县| 泰来县| 兴义市| 交口县| 德江县| 行唐县| 襄城县| 盐池县| 侯马市| 江西省| 普兰县| 务川| 额济纳旗| 基隆市| 徐州市| 高唐县| 钟山县| 泽普县| 江源县| 怀远县| 衡南县| 桑植县|